Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
CAPLIPOINT Stock Analysis
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
High and stable ROE
High and improving operating margin
Moderate EPS growth and above median growth of industry
Low Debt to Equity, not much change from last year
Consistently pays dividend
Company is net cash
Negative
Analysts have been downgrading forward EPS estimates
Low dividend yield
Neutral
Moderate revenue growth and in line with median growth of industry
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
CAPLIPOINT Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
CAPLIPOINT Bulk, Block & Insider Trades
CAPLIPOINT Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Stock split
Stock split(1 : 5)Nominal value change from INR 10 to INR 2. Ex-date: 19th Oct 2016 Announced on: 5th Aug 2016
Company Profile
Caplin Point Laboratories Limited is an India-based pharmaceutical company with a business model catering predominantly to emerging markets of Latin America and Africa. The Company has also entered regulated markets such as the United States through its Subsidiary, Caplin Steriles Limited. The Compa... Read More
Key personnel
Mr. Chingelput Chellappan PaarthipanD
Non-Executive Chairman of the Board
Mr. Ashok Gorkey PartheebanD
Non-Executive Vice Chairman of the Board
Mr. Vivek Siddharth PartheebanD
Non-Executive Vice Chairman of the Board
Mr. D. Muralidharan
Chief Financial Officer
Mr. G. Venkatram
Compliance Officer, General Counsel, Company Secretary
Dr. Sridhar GanesanD
Managing Director, Executive Director
Mr. S. DeenadhayalanD
Non-Executive Independent Director
Dr. Chanderkanta K. GariyaliD
Non-Executive Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently Asked Questions about CAPLIPOINT
What is the current share price of Caplin Point Laboratories Ltd.?
The current share price of Caplin Point Laboratories Ltd. is ₹ 1,727.22 as of 25 Feb 2026.
What is the PE ratio of Caplin Point Laboratories Ltd.?
The Price-to-Earnings (PE) ratio of Caplin Point Laboratories Ltd. is 21.39 as of the latest financial data.
What is the ROE and ROCE of Caplin Point Laboratories Ltd.?
Caplin Point Laboratories Ltd. has a Return on Equity (ROE) of 20.65% and a Return on Capital Employed (ROCE) of 21.77% as per the latest financial reports.
What is the market cap of Caplin Point Laboratories Ltd.?
The market capitalization of Caplin Point Laboratories Ltd. stands at ₹ 13,128.90 Cr.
What is the dividend yield of Caplin Point Laboratories Ltd.?
The dividend yield of Caplin Point Laboratories Ltd. is 0.35% based on the current market price.
What is the RSI of Caplin Point Laboratories Ltd.?
The Relative Strength Index (RSI) of Caplin Point Laboratories Ltd. is 44.16.
What is the FII and DII holding in Caplin Point Laboratories Ltd.?
Foreign Institutional Investors (FII) hold 6.55% and Domestic Institutional Investors (DII) hold 1.98% of Caplin Point Laboratories Ltd. shares.
What sector does Caplin Point Laboratories Ltd. belong to?
Caplin Point Laboratories Ltd. operates in the Healthcare sector.
What is the beta of Caplin Point Laboratories Ltd. stock?
The beta of Caplin Point Laboratories Ltd. stock is 1.15, indicating its volatility relative to the broader market.
